GRI BIO INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$1.53
-2.55%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-21.9%
3 months
+6.3%
6 months
-29.8%
1 year
-96.6%
Year to date
-77.9%
52-week range
$1.38 – $59.92
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$3.3M
P/E
-0.3
P/B
0.3
P/S
—
Revenue
$0
Net income
-$9.66M
Diluted EPS
-15.12
Gross margin
—
Net margin
—
Return on equity
-134.00%
Total debt
$44K
Cash
$10.95M
Free cash flow
-$10.42M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$1.64M | — | — | -$1.45M |
| Mar 31, 2026 | $0 | -$2M | — | — | -$3.69M |
| Dec 31, 2025 | $0 | -$2.66M | — | — | -$2.97M |
| Sep 30, 2025 | $0 | -$3.36M | — | — | -$2.31M |
| Sep 30, 2025 | $0 | -$3.36M | — | — | -$2.31M |
| Jun 30, 2025 | $0 | -$2.89M | — | — | -$3.17M |
| Mar 31, 2025 | $0 | -$3.05M | — | — | -$1.74M |
| Dec 31, 2024 | $0 | -$1.95M | — | — | -$2M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent GRI news
All market newsNo ticker-linked stories are in the current archive.